Seizert Capital Partners LLC Boosts Position in Option Care Health, Inc. $OPCH

Seizert Capital Partners LLC increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 118.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 127,523 shares of the company’s stock after buying an additional 69,055 shares during the period. Seizert Capital Partners LLC owned about 0.08% of Option Care Health worth $3,540,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its holdings in shares of Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after purchasing an additional 39,661 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after acquiring an additional 25,777 shares in the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health during the first quarter valued at $208,000. Assenagon Asset Management S.A. boosted its stake in shares of Option Care Health by 227.1% during the second quarter. Assenagon Asset Management S.A. now owns 635,758 shares of the company’s stock valued at $20,649,000 after acquiring an additional 441,417 shares during the last quarter. Finally, Wedge Capital Management L L P NC increased its position in Option Care Health by 12.8% during the 2nd quarter. Wedge Capital Management L L P NC now owns 133,389 shares of the company’s stock worth $4,332,000 after purchasing an additional 15,102 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on OPCH. Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Citizens Jmp restated a “market outperform” rating and set a $38.00 price objective (up previously from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. Morgan Stanley boosted their price objective on Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a report on Tuesday, January 13th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a report on Tuesday, December 9th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $37.50.

Option Care Health Stock Performance

OPCH opened at $36.04 on Tuesday. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.32. The stock has a market cap of $5.72 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 2.15 and a beta of 0.80. The business’s 50 day moving average is $31.66 and its 200-day moving average is $29.54. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.